Package 68475-514-02

Brand: hydralazine hydrochloride

Generic: hydralazine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68475-514-02
Digits Only 6847551402
Product NDC 68475-514
Description

25 VIAL in 1 PACKAGE (68475-514-02) / 1 mL in 1 VIAL (68475-514-01)

Marketing

Marketing Status
Marketed Since 2025-11-25
Brand hydralazine hydrochloride
Generic hydralazine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "99678e1f-ed3c-48a8-8902-33f407eb0d8c", "openfda": {"upc": ["0368475514010"], "unii": ["FD171B778Y"], "rxcui": ["966571"], "spl_set_id": ["ae5d85df-11a3-4952-ade2-596d57cdd987"], "manufacturer_name": ["Navinta LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 PACKAGE (68475-514-02)  / 1 mL in 1 VIAL (68475-514-01)", "package_ndc": "68475-514-02", "marketing_start_date": "20251125"}], "brand_name": "Hydralazine Hydrochloride", "product_id": "68475-514_99678e1f-ed3c-48a8-8902-33f407eb0d8c", "dosage_form": "INJECTION", "pharm_class": ["Arteriolar Vasodilation [PE]", "Arteriolar Vasodilator [EPC]"], "product_ndc": "68475-514", "generic_name": "Hydralazine Hydrochloride", "labeler_name": "Navinta LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydralazine Hydrochloride", "active_ingredients": [{"name": "HYDRALAZINE HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA202938", "marketing_category": "ANDA", "marketing_start_date": "20251125", "listing_expiration_date": "20261231"}